599 related articles for article (PubMed ID: 22197229)
41. [Volumetric and geometric changes of parotids occurring during IMRT for nasopharyngeal carcinoma (NPC) using daily CBCT].
Yang BB; Wang J; Zhong RM; Jiang QF; Chen NY; Bai S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):1024-8. PubMed ID: 21265108
[TBL] [Abstract][Full Text] [Related]
42. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
Wang W; Yang H; Hu W; Shan G; Ding W; Yu C; Wang B; Wang X; Xu Q
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):617-21. PubMed ID: 20138444
[TBL] [Abstract][Full Text] [Related]
43. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
44. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
[TBL] [Abstract][Full Text] [Related]
45. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
46. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
47. Is uniform target dose possible in IMRT plans in the head and neck?
Vineberg KA; Eisbruch A; Coselmon MM; McShan DL; Kessler ML; Fraass BA
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1159-72. PubMed ID: 11955726
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
49. Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature.
Loo SW; Martin WM; Smith P; Cherian S; Roques TW
Br J Radiol; 2012 Aug; 85(1016):1070-7. PubMed ID: 22815411
[TBL] [Abstract][Full Text] [Related]
50. The dilemma of parotid gland and pharyngeal constrictor muscles preservation-Is daily online image guidance required? A dosimetric analysis.
Duffy O; Forde E; Leech M
Med Dosim; 2017 Spring; 42(1):24-30. PubMed ID: 28126473
[TBL] [Abstract][Full Text] [Related]
51. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
52. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer.
Maheshwari G; Dhanawat A; Kumar HS; Sharma N; Jakhar SL
J Cancer Res Ther; 2020; 16(3):600-604. PubMed ID: 32719274
[TBL] [Abstract][Full Text] [Related]
53. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation.
Landry G; Nijhuis R; Dedes G; Handrack J; Thieke C; Janssens G; Orban de Xivry J; Reiner M; Kamp F; Wilkens JJ; Paganelli C; Riboldi M; Baroni G; Ganswindt U; Belka C; Parodi K
Med Phys; 2015 Mar; 42(3):1354-66. PubMed ID: 25735290
[TBL] [Abstract][Full Text] [Related]
54. Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands.
Fiorentino A; Cozzolino M; Caivano R; Pedicini P; Chiumento C; Oliviero C; Clemente S; Fusco V
Clin Transl Oncol; 2013 May; 15(5):412-5. PubMed ID: 23065602
[TBL] [Abstract][Full Text] [Related]
55. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
[TBL] [Abstract][Full Text] [Related]
56. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
[TBL] [Abstract][Full Text] [Related]
57. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.
Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L
Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052
[TBL] [Abstract][Full Text] [Related]
58. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.
Claus F; Duthoy W; Boterberg T; De Gersem W; Huys J; Vermeersch H; De Neve W
Oral Oncol; 2002 Sep; 38(6):597-604. PubMed ID: 12167438
[TBL] [Abstract][Full Text] [Related]
59. Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.
Miah AB; Gulliford SL; Morden J; Newbold KL; Bhide SA; Zaidi SH; Hall E; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e69-e76. PubMed ID: 26994893
[TBL] [Abstract][Full Text] [Related]
60. Dose calculation and treatment plan optimization including imaging dose from kilovoltage cone beam computed tomography.
Alaei P; Spezi E; Reynolds M
Acta Oncol; 2014 Jun; 53(6):839-44. PubMed ID: 24438661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
